Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells

Journal of Neuroscience Research

Volumn 72, Issue 3, 2003, Pages 303-316

  Vaudry, David ^a   Falluel Morel, Anthony ^a   Basille, Magali ^a   Pamantung, Tommy F ^a   Fontaine, Marc ^b   Fournier, Alain ^c   Vaudry, Hubert ^a   Gonzalez, Bruno J ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b INSERM   (France)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Caspases; Development; MAP kinases; Neuropeptides; Sphingolipids

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENYLATE CYCLASE; BUCLADESINE; CASPASE 3; CERAMIDE; CHELERYTHRINE; DNA FRAGMENT; FORSKOLIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SPHINGOLIPID; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CELL CULTURE; CELL DEATH; CELL KINETICS; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; GRANULE CELL; INHIBITION KINETICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CERAMIDES; CEREBELLUM; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 0037404665     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10530     Document Type: Article

References (63)

1. Altman J. 1972. Postnatal development of the cerebellar cortex in the rat. I. The external germinal layer and the transitional molecular layer. J Comp Neurol 145:353-397.
2. Arimura A. 1998. Perspectives on pituitary adenylate cyclase-activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301-331.
3. Ariga T, Jarvis WD, Yu RK. 1998. Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39:1-16.
4. Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES, Litwack G, Karanewsky DS, Fritz LC, Tomaselli KJ. 1997. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 17:553-562.
5. Basille M, Gonzalez BJ, Desrues L, Demas M, Fournier A, Vaudry H. 1995. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts. J Neurochem 65:1318-1324.
6. Basille M, Gonzalez BJ, Fournier A, Vaudry H. 1994. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study. Brain Res Dev Brain Res 82:81-89.
7. Basille M, Gonzalez BJ, Leroux P, Jeandel L, Fournier A, Vaudry H. 1993. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells. Neuroscience 57:329-338.
8. Basille M, Vaudry, D, Coulouarn Y, Jégou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez BJ. 2000. Distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in germinative neuroepithelia of the rat, J Comp Neurol 425: 495-509.
9. Blanco-Aparicio C, Torres J, Pulido R. 1999. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J Cell Biol 147:1129-1136.
10. Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS. 2000. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem 275:9628-9635.
11. Buscà R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Eychene A, Ortonne JP, Ballotti K. R. 2000. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J 19:2900-2910.
12. Campard PK, Crochemore C, Rene F, Monnier D, Koch B, Loeffier JP. 1997. PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol 16:323-333.
13. Cavallaro S, Copani A, D'Agata V, Musco S, Petralia S, Ventra C, Stivala F, Travali S, Canonico PL. 1996. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol 50:60-66.
14. Chartrel N, Tonon MC, Vaudry H, Conlon JM. 1991. Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology 129:3367-3371.
15. Cuvillier O, Edsall L, Spiegel S. 2000. Involvement of sphingosine in mitochondria-dependent Fas-Induced apoptosis of type II Jurkat T cells. J Biol Chem 275:15691-15700.
16. DiCicco-Bloom E, Deutsch PJ, Maltzman J, Zhang J, Pintar JE, Zheng J, Friedman WF, Zhou X, Zaremba T. 2000. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sym pathetic development. Dev Biol 219:197-213.
17. D'Mello SR, Kuan CY, Flavell RA, Rakic P. 2000. Caspase-3 is required for apoptosis-associated DNA fragmentation but not for cell death in neurons deprived of potassium. J Neurosci Res 59:24-31.
18. Edsall LC, Cuvillier O, Twitty S, Spiegel S, Milstien S. 2001. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J Neurochem 76:1573-1584.
19. Favit A, Scapagnini U, Canonico PL. 1995. Pituitary adenylate cyclase-activating polypeptide activates different signal transducing mechanisms in cultured cerebellar granule cells. Neuroendocrinology 61:377-382.
20. Gallo V, Kingsbury A, Balazs R, Jorgensen OS. 1987. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci 7:2203-2213.
21. Gonzalez BJ, Basille M, Vaudry D, Fournier A, Vaudry H. 1997. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience 78:419-430.
22. Gonzalez BJ, Leroux P, Lamacz M, Bodenant C, Balazs R, Vaudry H. 1992. Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity. Proc Natl Acad Sci USA 89:9627-9631.
23. Hannun YA, Luberto C. 2000. Ceramide in the eukaryotic stress response. Trends Cell Biol 10:73-80.
24. Harada J, Sugimoto M. 1999. An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Jpn J Pharmacol 79:369-378.
25. Herget T, Esdar C, Oehrlein SA, Heinrich M, Schutze S, Maelicke A, Van Echten-Deckert G. 2000. Production of ceramides causes apoptosis during early neural differentiation in vitro. J Biol Chem 275:30344-30354.
26. Karin M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486.
27. Kondo T, Matsuda T, Kitano T, Takahashi A, Tashima M, Ishikura H, Umehara H, Domae N, Uchiyama T, Okazaki T. 2000. Role of c-jun expression increased by heat shock- and ceramide-activated caspase-3 in HL-60 cell apoptosis. Possible involvement of ceramide in heat shock-induced apoptosis. J Biol Chem 275:7668-7676.
28. Kuan CY, Roth KA, Flavell RA, Rakic P. 2000 Mechanisms of programmed cell death in the developing brain. Trend Neurosci 23:291-297.
29. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325-337.
30. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003.
31. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA. 1996 Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372.
32. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret FX, Green DR, Karin M. 1999. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol 19:751-763.
33. Lelièvre V, Zhonting H, Byun J-Y, Ioffe Y, Waschek JA. 2002. Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition. J Neurosci Res 67:566-573.
34. Liu X, Zou H, Slaughter C, Wang X. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184.
35. Nielsen HS, Hannibal J, Fahrenkrug J. 1998 Expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the postnatal and adult rat cerebellar cortex. Neuroreport 9:2639-2642.
36. Pagès G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouyssegur J. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374-1377.
37. Ramage P, Cheneval D, Chvei M, Graff P, Hemmig R, Heng R, Kocher HP, MacKenzie A, Memmert K, Revesz L. 1995. Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem 270:9378-9383.
38. Sée V, Koch B, Loeffler JP. 2001. C2-ceramide and reactive oxygen species inhibit pituitary adenylate cyclase activating polypeptide (PACAP)-induced cyclic-AMP-dependent signalling pathway. J Neurochem 76:778-788.
39. Schwarz A, Futerman AH. 1997, Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J Neurosci 17:2929-2938.
40. Stennick HR, Ryan CA, Salvesen GS. 2002. Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 27:94-101.
41. Sugiura N, Suga T, Ozeki Y, Mamiya G, Takishima K. 1997. The mouse extracellular signal-regulated kinase 2 gene. J Biol Chem 272:21575-21581.
42. Suh J, Lu N, Nicot A, Tatsuno I, DiCicco-Bloom E. 2001. PACAP is an anti-mitogenic signal in developing cerebral cortex. Nat Neurosci 4:123-124.
43. Taniwaki T, Yamada T, Asahara H, Ohyagi Y, Kira J. 1999. Ceramide induces apoptosis to immature cerebellar granule cells in culture. Neurochem Res 24:685-690.
44. Tepper AD, Cock JG, de Vries E, Borst J, van Blitterswijk WJ. 1997. CD95/Fas-induced ceramide formation proceeds with slowkinetics and is not blocked by caspase-3/CPP32 inhibition. J Biol Chem 272:24308-24312.
45. Testi R. 1996. Sphingomyelin breakdown and cell fate. Trends Biochem Sci 21:468-471.
46. Toman RE, Movsesyan V, Murthy SK, Milstien S, Spiegel S, Faden AI. 2002. Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. J Neurosci Res 68:323-330.
47. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874.
48. Valladares A, Porras A, Alvarez AM, Roncero C, Benito M. 2000. Noradrenaline induces brown adipocytes cell growth via beta-receptors by a mechanism dependent on ERKs but independent of cAMP and PKA. J Cell Physiol 185:324-330.
49. Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, Vaudry H. 1998. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84:801-812.
50. Vaudry D, Gonzalez BJ, Basille M, Fournier A, Vaudry H. 1999. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc Natl Acad Sci USA 96:9415-9420.
51. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. 20002a. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324.
52. Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H. 2000b. Pituitary adenylate cyclase-activating polypeptide inhibits apoptosis of rat cerebellar granule neurons through involvement of caspase-3/CPP32. Proc Natl Acad Sci USA 97:13390-13395.
53. Villalba M, Bockaert J, Journot L. 1997. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17:83-90.
54. Waschek JA, Casillas RA, Nguyen TB, DiCicco-Bloom EM, Carpenter EM, Rodriguez WI. 1998. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc Natl Acad Sci USA 95:9602-9607.
55. Watson A, Eilers A, Lallemand D, Kyriakis J, Rubin LL, Ham J. 1998. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J Neurosci 18:751-762.
56. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B. 2001. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 13:2037-2046.
57. Whyte M, Evan G. 1995. Apoptosis. The last cut is the deepest. Nature 376:7-18.
58. Wood KA, Dipasquale B, Youle RJ. 1993. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 11:621-632.
59. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK, and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
60. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, Sandhoff K, Proia RL. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA 96:9142-9147.
61. Yuan J and Yankner BA. 2000. Apoptosis in the nervous system. Nature 407:802-809.
62. Zhou CJ, Shioda S, Shibanuma M, Nakajo S, Funahashi H, Nakai Y, Arimura A, Kikuyama S. 1999. Pituitary adenylate cyclase-activating polypeptide receptors during development: expression in the rat embryo at primitive streak stage. Neuroscience 93:375-391.
63. Zùniga A, Torres J, Ubeda J, Pulido R. 1999. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J Biol Chem 274:21900-21907.